Skip to main content

Part of Cancer staging guidance sheets

Carcinoma of lacrimal gland (ICD10 C69.5)

Previous Chapter

Malignant melanoma of uvea

Current Chapter

Current chapter – Carcinoma of lacrimal gland (ICD10 C69.5)

View all

Next Chapter

Sarcoma of orbit

Page contents

Introduction

This is the data sheet for TNM 8th edition staging of the carcinoma of lacrimal gland (ICD10 C69.5).

For more detailed information regarding TNM staging, please see pages 232-233 of the UICC TNM 8 book or visit the Wiley and UICC website.

TNM clinical classification

T - primary tumour

T value Description

TX

Primary tumour cannot be assessed

T0

No evidence of primary tumour

T1

Tumour 2 cm or less in greatest dimension, with or without extraglandular extension into the orbital soft tissue

T1a - No periosteal or bone involvement

T1b - Periosteal involvement without bone involvement

T1c - Bone involvement

T2

Tumour more than 2 cm but not more than 4 cm in greatest dimension T2a - No periosteal or bone involvement

T2b - Periosteal involvement without bone involvement

T2c - Bone involvement

T3

Tumour more than 4 cm or with extraglandular extension into orbital soft tissue, including optic nerve, or globe

T3a - No periosteal or bone involvement

T3b - Periosteal involvement without bone involvement

T3c - Bone involvement

T4

Tumour invades adjacent structures (sinuses, temporal fossa, pterygoid fossa, superior orbital fissure, cavernous sinus, and/or brain)

T4a - No more than 2 cm in greatest dimension

T4b - More than 2 cm but no more than 4 cm in greatest dimension

T4c - More than 4 cm in greatest dimension

N - regional lymph nodes

N value Description

NX

Regional lymph nodes cannot be assessed

N0

No regional lymph node metastasis

N1

Regional lymph node metastasis

M - distant metastasis

M value Description

M0

No distant metastasis

M1

Distant Metastasis

TNM pathological classification

pT - primary tumour

The pT and pN categories correspond to the T and N categories.

 

Download

Click on the box below to download a PDF version of this data sheet:

Last edited: 29 December 2022 2:37 pm

Previous Chapter

Malignant melanoma of uvea

Next Chapter

Sarcoma of orbit
  1. Cancer staging guidance sheets
  2. Lip and oral cavity (ICD10 C00, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C10-14, C30-32)
  4. Pharynx (ICD10 C01, C05.1-2, C09, C10.0, C10.2-3, C11-13)
  5. Major salivary glands (ICD10 C07, C08)
  6. Oesophagus including oesophagastric junction (ICD10 C15 & C16.0)
  7. Stomach (ICD10 C16 except C16.0)
  8. Small intestine (ICD10 C17)
  9. Appendix (ICD10 C18.1)
  10. Colon and rectum (ICD10 C18-C20)
  11. Anal canal and perianal skin data (ICD10 C21, C44.5)
  12. Liver (ICD10 C22.0)
  13. Intrahepatic bile ducts (ICD10 C22.1)
  14. Gallbladder (ICD10 C23, C24.0)
  15. Distal extrahepatic bile duct (ICD10 C24.0)
  16. Perihilar bile ducts (ICD10 C24.0)
  17. Ampulla of vater (ICD10 C24.1)
  18. Pancreas (ICD10 C25)
  19. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  20. Larynx (ICD10 C32.0 C32.1, C32.2, C10.1)
  21. Lung (ICD10 C34)
  22. Thymic tumours (ICD10 C37)
  23. Soft tissues (ICD10 C38.1-2, C47-C49)
  24. Bone (ICD10 C40 & C41)
  25. Malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)
  26. Merkel cell carcinoma of skin (ICD10 C44 & C63.2)
  27. Skin carcinoma of the head and neck (ICD10 C44.0, C44.2-4)
  28. Carcinoma of skin of the eyelid (ICD10 C44.1)
  29. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  30. Pleural mesothelioma (ICD10 C45)
  31. Breast tumours (ICD10 C50)
  32. Vulva (ICD10 C51)
  33. Cervix uteri (ICD10 C53)
  34. Uterine sarcomas
  35. Uterus - endometrium (ICD10 C54.1, C55)
  36. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  37. Gestational trophoblastic neoplasms (ICD10 C58)
  38. Penis tumours (ICD10 C60)
  39. Prostate tumours (ICD10 C61)
  40. Testis tumours (ICD10 C62)
  41. Kidney tumours (ICD10 C64)
  42. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  43. Urinary bladder tumours (ICD10 C67)
  44. Urethra tumours (ICD10 C68.0)
  45. Carcinoma of conjuctiva (ICD10 C69.0)
  46. Malignant melanoma of conjuctiva (ICD10 C69.0)
  47. Retinoblastoma (ICD10 C69.2)
  48. Malignant melanoma of uvea (ICD10 C69.3, C69.4)
  49. Carcinoma of lacrimal gland (ICD10 C69.5)
  50. Sarcoma of orbit (ICD10 C69.6)
  51. Thyroid gland (ICD10 C73)
  52. Adrenal cortex (ICD10 C74.0)
  53. Chronic lymphocytic leukaemia
  54. Hepatoblastoma (CTYA)
  55. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  56. Medulloblastoma
  57. Multiple myeloma
  58. Neuroblastoma
  59. Neuroendocrine tumours of the foregut
  60. Neuroendocrine tumours of the midgut and hindgut
  61. Non-hodgkin lymphoma (children)
  62. Rhabdomyosarcoma and other soft tissue sarcomas (CTYA)
  63. Wilms tumour of the kidney